Arrowstreet Capital’s Qiagen QGEN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-5,412
| Closed | -$248K | – | 1972 |
|
|
2024
Q4 | $248K | Sell |
5,412
-8,850
| -62% | -$396K | ﹤0.01% | 1648 |
|
|
2024
Q3 | $668K | Buy |
+14,262
| New | +$650K | ﹤0.01% | 1471 |
|
|
2024
Q2 | – | Sell |
-346,659
| Closed | -$15.3M | – | 1726 |
|
|
2024
Q1 | $15.3M | Buy |
346,659
+98,037
| +39% | +$4.47M | 0.01% | 568 |
|
|
2023
Q4 | $11.5M | Sell |
248,622
-342,088
| -58% | -$14.5M | 0.01% | 530 |
|
|
2023
Q3 | $25.4M | Sell |
590,710
-678,899
| -53% | -$31.7M | 0.03% | 342 |
|
|
2023
Q2 | $60.5M | Sell |
1,269,609
-1,345,534
| -51% | -$64.9M | 0.07% | 217 |
|
|
2023
Q1 | $127M | Sell |
2,615,143
-874,456
| -25% | -$44.5M | 0.16% | 144 |
|
|
2022
Q4 | $185M | Buy |
3,489,599
+203,205
| +6% | +$10M | 0.26% | 109 |
|
|
2022
Q3 | $145M | Buy |
3,286,394
+95,119
| +3% | +$4.7M | 0.21% | 119 |
|
|
2022
Q2 | $159M | Sell |
3,191,275
-107,562
| -3% | -$5.25M | 0.23% | 111 |
|
|
2022
Q1 | $172M | Buy |
3,298,837
+409,732
| +14% | +$21.1M | 0.21% | 123 |
|
|
2021
Q4 | $171M | Buy |
2,889,105
+1,334,939
| +86% | +$76.5M | 0.21% | 121 |
|
|
2021
Q3 | $85.3M | Buy |
1,554,166
+1,457,175
| +1,502% | +$81.1M | 0.11% | 212 |
|
|
2021
Q2 | $4.97M | Buy |
+96,991
| New | +$5.01M | 0.01% | 1074 |
|
|
2021
Q1 | – | Sell |
-600,423
| Closed | -$33.3M | – | 2474 |
|
|
2020
Q4 | $33.3M | Buy |
600,423
+213,699
| +55% | +$11.4M | 0.05% | 399 |
|
|
2020
Q3 | $21.3M | Sell |
386,724
-214,107
| -36% | -$11.1M | 0.03% | 531 |
|
|
2020
Q2 | $27.4M | Buy |
+600,831
| New | +$26.9M | 0.05% | 377 |
|
|
2020
Q1 | – | Sell |
-158,646
| Closed | -$5.71M | – | 2069 |
|
|
2019
Q4 | $5.71M | Sell |
158,646
-36,834
| -19% | -$1.37M | 0.01% | 819 |
|
|
2019
Q3 | $6.83M | Buy |
195,480
+80,479
| +70% | +$3.1M | 0.02% | 612 |
|
|
2019
Q2 | $4.95M | Sell |
115,001
-179,238
| -61% | -$7.43M | 0.01% | 649 |
|
|
2019
Q1 | $12.7M | Buy |
+294,239
| New | +$11.8M | 0.03% | 484 |
|
|
2018
Q4 | – | Sell |
-750,268
| Closed | -$30.1M | – | 1473 |
|
|
2018
Q3 | $30.1M | Buy |
750,268
+19,038
| +3% | +$761K | 0.07% | 240 |
|
|
2018
Q2 | $28.1M | Buy |
+731,230
| New | +$26.9M | 0.07% | 255 |
|
|
2018
Q1 | – | Sell |
-202,812
| Closed | -$6.69M | – | 1297 |
|
|
2017
Q4 | $6.69M | Sell |
202,812
-448,048
| -69% | -$15.4M | 0.02% | 544 |
|
|
2017
Q3 | $21.7M | Sell |
650,860
-91,891
| -12% | -$3.17M | 0.06% | 276 |
|
|
2017
Q2 | $26.4M | Buy |
+742,751
| New | +$25.1M | 0.08% | 215 |
|
Other funds holding QGEN
Arrowstreet Capital's QGEN Position: Q1 2025 in Review
Arrowstreet Capital sold out of Qiagen (QGEN) in Q1 2025, closing a stake of 5,412 shares — an estimated $248K sold.
Arrowstreet Capital first reported a position in QGEN in Q2 2017 and held it in 26 quarters. The position peaked at $185M in Q4 2022. 298 funds tracked by Wall St. Rank hold QGEN as of Q1 2025.
- Arrowstreet Capital reported no remaining Qiagen position as of Q1 2025 after selling out during the quarter.
- Arrowstreet Capital sold 5,412 Qiagen shares in Q1 2025, an estimated $248K.
- Arrowstreet Capital first reported a position in Qiagen in Q2 2017 and held it in 26 quarters.
- Arrowstreet Capital's Qiagen position peaked at $185M in Q4 2022.
- 298 funds tracked by Wall St. Rank held Qiagen as of Q1 2025.
Based on Arrowstreet Capital's 13F filing for Q1 2025, filed 14 May 2025.